Breast cancers which are positive for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) represent discrete biological entities with distinct clinical profiles and are often associated with better prognosis and can be treated with hormone therapy. This evidence concerns the gene ERBB2 and breast cancer.